Barclays
ACB

Barclays’s Aurora Cannabis ACB Stock Holding History

Barclays’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.4K Sell
22,001
-5,716
-21% -$19.1K ﹤0.01% 4249
2026
Q1 		$90.6K Sell
27,717
-5,992
-18% -$22.6K ﹤0.01% 4068
2025
Q4 		$142K Buy
33,709
+16,292
+94% +$79.7K ﹤0.01% 4471
2025
Q3 		$104K Buy
17,417
+11,100
+176% +$54.2K ﹤0.01% 4603
2025
Q2 		$26.8K Buy
6,317
+3,900
+161% +$18.9K ﹤0.01% 4806
2025
Q1 		$10.6K Buy
2,417
+2,400
+14,118% +$11.3K ﹤0.01% 4861
2024
Q4 		$72 Hold
17
– – ﹤0.01% 5189
2024
Q3 		$100 Sell
17
-25,140
-100% -$149K ﹤0.01% 5182
2024
Q2 		$116K Buy
25,157
+1,501
+6% +$9.5K ﹤0.01% 3837
2024
Q1 		$104K Buy
23,656
+1,399
+6% +$5.41K ﹤0.01% 4419
2023
Q4 		$106K Sell
22,257
-2,450
-10% -$11.8K ﹤0.01% 4626
2023
Q3 		$145K Sell
24,707
-2,350
-9% -$13.7K ﹤0.01% 3435
2023
Q2 		$145K Buy
27,057
+400
+2% +$2.36K ﹤0.01% 3404
2023
Q1 		$186K Buy
26,657
+1,507
+6% +$13.2K ﹤0.01% 3834
2022
Q4 		$232K Buy
25,150
+1,890
+8% +$22.5K ﹤0.01% 3761
2022
Q3 		$284K Buy
23,260
+21,750
+1,440% +$320K ﹤0.01% 3010
2022
Q2 		$19K Sell
1,510
-4,215
-74% -$106K ﹤0.01% 4417
2022
Q1 		$229K Buy
+5,725
New +$243K ﹤0.01% 3335
2020
Q2 		– Sell
-5,680
Closed -$617K – 5487
2020
Q1 		$617K Sell
5,680
-706
-11% -$126K ﹤0.01% 3413
2019
Q4 		$1.66M Buy
6,386
+6,125
+2,347% +$2.28M ﹤0.01% 3195
2019
Q3 		$138K Sell
261
-3,054
-92% -$2.26M ﹤0.01% 5228
2019
Q2 		$3.12M Buy
3,315
+1,018
+44% +$1.02M ﹤0.01% 2387
2019
Q1 		$2.5M Buy
2,297
+2,258
+5,790% +$2.02M ﹤0.01% 2336
2018
Q4 		$23K Buy
+39
New +$28.8K ﹤0.01% 5829

Other funds holding ACB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Barclays's ACB Position: Q2 2026 in Review

Barclays reduced its Aurora Cannabis (ACB) stake by 21% in Q2 2026, selling an estimated $19.1K and leaving 22,001 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Barclays first reported a position in ACB in Q4 2018 and has held it in 24 quarters since. The position peaked at $3.12M in Q2 2019. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

  • Barclays held 22,001 shares of Aurora Cannabis worth $61.4K as of Q2 2026.
  • Barclays sold 5,716 Aurora Cannabis shares in Q2 2026, an estimated $19.1K.
  • Aurora Cannabis made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4249 holding.
  • Barclays first reported a position in Aurora Cannabis in Q4 2018 and has held it in 24 quarters since.
  • Barclays's Aurora Cannabis position peaked at $3.12M in Q2 2019.
  • 149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.